Health in China
Get more with myNEWS
A personalised news feed of stories that matter to you
Learn more
Foreign brands are seen as ‘way more trustworthy’ than domestic rivals and that is not likely to change soon, according to Dan Wang, of the Economic Intelligence Unit. Illustration: SCMP

China’s parents haunted by melamine baby milk scandal still favour foreign brands

  • Domestic makers of baby powder rebuild their market share to 44 per cent, all down to Feihe which was not caught up in the 2008 tragedy
  • Foreign brands are seen as “way more trustworthy” and this reputation is likely to last for very long time, EIU says

Twelve years ago, 300,000 children in China were poisoned after drinking infant milk formula that contained melamine, a chemical used in plastic. Six babies were killed by the toxic substance, which was used by 22 companies to artificially boost the protein levels that showed up in nutrition tests.

Those responsible were punished with sentences ranging from lengthy prison terms to the death penalty.

Dubbed the ‘melamine scandal’, the tragedy rocked China’s baby milk formula industry. Many parents lost their trust in domestic brands, paving the way for foreign companies to charge ahead in a market Euromonitor predicts will be worth US$32 billion by 2023. Only about a quarter of Chinese mothers breast feed.

A baby receives medical treatment at a hospital in China on September 14, 2008. Dubbed the ‘melamine scandal’, the tragedy rocked China’s baby milk formula industry. Photo: Reuters

More than a decade on, China’s dairy industry is still shrouded in mistrust. Its largest infant milk producer, China Feihe, is the only domestic baby powder company that has emerged largely unscathed, touted as the brand to take on international giants like Nestle and Danone. Feihe did not have any melamine in its products.

Analysts say there is still a way to go before consumers fully trust and actively choose domestic producers over foreign rivals, and that gains in overall market share by local companies in recent years are almost entirely down to Feihe’s success. Foreign brands say China is a hugely important market they intend to continue expanding in.

Action needed to put a lid on trade in baby milk formula

“Foreign brands are seen as way more trustworthy than domestic ones and this reputation is likely to last for a very long time, particularly for middle-class cities,” said Dan Wang, China analyst for the Economic Intelligence Unit (EIU). Anything that harms babies in a country that, until 2015, enforced a one-child policy, will destroy consumer confidence, she said.

Both Wang, and Robin Yuen, consumer analyst for Singaporean investment bank UOB-Kay Hian, said parents would choose to buy foreign-branded baby powder if they can afford it.

“Those in tier-1 cities, they still prefer the top international brands,” said Yuen. “A lot of the domestic brands are winning shares in the lower-tier cities.”

Chinese cities are categorised into tiers, with the biggest, most advanced and wealthiest in tier 1.

Even Feihe’s strongest customer network is in lower tier, less wealthy cities, according to brokerage CCB International Securities (CCBIS), though it has been expanding into top tier cities in recent years.

Meanwhile other scandals – like the substandard vaccines given to Chinese babies in 2018 – have only added to consumer worries stemming from the melamine scandal about a lack of transparency in the quality of infant products.

Some brands are using crises like the current coronavirus outbreak as a way to foster customer bonds, with Danone and Feihe launching free online medical consultation services for patients. Both have also been delivering products for free, and Feihe has donated 100 million yuan to the China Red Cross Foundation.

“It’s not the domestic brands, per se, that consumers do not trust, but the lack of transparency in quality management, as well as local governments’ over-willingness to protect their local champions to ensure growth and employment,” said EIU’s Wang.

Last June, China’s National Development and Reform Commission (NDRC) set a goal for domestic baby milk formula producers to take a more than 60 per cent share of the national market, in a clear signal that Beijing is trying to reduce reliance on imported milk formula and make domestic companies more competitive. It did not set a deadline for this target.

The government has also tightened its supervision and rules around the registration of infant milk formula companies and products, manufacturing standards and advertising practices.

In 2018, Chinese producers accounted for 44 per cent of the domestic infant milk formula market, according to US market research firm Nielsen.

Feihe was the second-largest player among domestic and international companies, in terms of retail sales value, according to research firm Frost & Sullivan, with a 7.3 per cent stake in the market, up from 3.4 per cent in 2016.

Zhang Ziyi’s baby milk formula producer Feihe aims for Hong Kong IPO

Among only domestic companies it had the largest market share – 15.6 per cent in 2018, up from 7.4 per cent in 2016. Feihe saw revenue of 10.4 billion yuan (US$1.5 billion) in the same year, with premium infant milk accounting for 64 per cent of that. Net profit was 2.2 billion yuan.

The company sells infant milk formula in more than 100,000 stores and has over 5,400 employees in China, according to data from Bloomberg.

Though statistics show domestic producers’ overall market share is growing, UOB’s Yuen said this is essentially a one-company achievement.

The 2008 melamine scandal is “still in the minds of Chinese consumers,” he said, and companies most heavily implicated at the time would have to totally rebrand themselves to escape past associations and do well.

“Aside from the Feihe’s success, I cannot pick up any immediate domestic brand that is really strong right now,” said Yuen. “It is more [a matter of] momentum from a brand specifically winning consumer confidence and minds, than a whole industry wave with consumers buying domestic [brands] because they’ve forgotten the melamine scandal.”

In November, Morgan Stanley-backed Feihe listed in Hong Kong for HK$6.7 billion, after chairman Youbin Leng delisted the then holding company, Flying Crane, in the US in 2013. Over the years it has built a reputation for transparency, quality controls and making products as close as possible to Chinese mothers’ breast milk, with a focus on premium products.

China Feihe’s chairman Leng Youbin at the stock listing ceremony at the Hong Kong stock exchange on November 13. Photo: China News Service via Getty Images

Feihe’s stock has soared by 66 per cent since its listing in November.

According to CCBIS, it has 25 quality control procedures with over 300 checkpoints, from inspecting the food given to the cattle, through to product delivery.

“Feihe was one of the very few infant formula companies that did not have any melamine crisis,” said Leng. “A big reason was that we were the first to set up a complete vertical integration system.

“At the time of the melamine crisis, we owned two of the dairy farms so the safety of not just the milk that went into our infant formula, but the feed of what the cows ate … and that quality, was also ensured.”

About half of the cows in Feihe’s Yuanshengtai Dairy Farm are milking and will come to the parlour three times a day to be milked. Photo: Tom Wang

“We were accepted by not just the overall industry but even other competitors and the government as a model for what to do in terms of really having the best quality.”

Leng, who in 2018 was chosen as a delegate to represent Heilongjiang province, grew up raising dairy cows, and studied food science technology in Shanghai before joining Feihe – then known as Zhaoguang Dairy – in 1987. “This is my life’s work,” he said.

A picture of Leng’s child is among a collage of employees’ smiling babies on a wall at the entrance to the company’s Beijing headquarters, reminding staff who they are working for.

About 2,000 kilometres north east is where Feihe produces its goods, in Heilongjiang province.

Close to the province’s northwestern border with Inner Mongolia is Gannan county, home to one of the firm’s six source farms.

Owned by dairy farming company YuanShengTai, it spans 960,000 square metres and houses 10,000 cows, about half of which churn out milk. Calves huddle in nearby sheds, some wearing pink coats to protect them from the harsh Heilongjiang winter, where temperatures often drop to around minus 25 degrees Celsius.

Calves, with identification tags, wear vests to keep warm in one of Feihe’s facilities in Heilongjiang. Photo: Tom Wang

The cows, belonging to a breed called Holstein, were originally imported from Australia and New Zealand, for their superior quality, and are selectively bred by the farm. They eat feed from the US and are milked three times a day to the sound of European classical music.

Each day around 180 tonnes of fresh milk is driven 20 minutes to Feihe’s Gannan production facility, the largest of five. Within 24 hours it goes through a two-hour process to be turned into infant milk formula. Aside from factory machinery and production lines, which run 24/7, the facility also has about 80 scientists working around the clock to test levels of minerals, vitamins and nutrients in each batch.

A milk truck is preparing to deliver the cow milk from a facility in Heilongjiang to the China Feihe milk-formula lab for quality testing. Photo: Tom Wang

The end product is fitted with a tracking system, enabling consumers to scan a QR code on WeChat to see the entire production process.

Last week Danone also launched a tracking service in China for consumers and retailers to trace “from farm to fork”, to verify authenticity and quality. It will also be rolled out in France, Germany, Australia and New Zealand this year.

In its first venture abroad, Feihe started building a production facility in Kingston, Canada, in 2017, and will begin to produce formula from cow and goat milk there this year. It will be sold in North America, Southeast Asia and some in China, under a different branding to look like a foreign product.

Though Leng insists trust in domestic players has returned to Chinese consumers, “there is still a segment that will enjoy multinational [products], and drink foreign brands,” he said.

Foreign companies like Danone, Bubs Australia, and New Zealand’s The a2 Milk Company, are banking on Chinese consumers continuing to turn to overseas makers of infant milk formula.

China makes up 9 per cent of global sales for Danone, which brings in milk from Germany, the Netherlands, Ireland and New Zealand. It said China “plays a very important role in Danone business,” in an email to the Post.

Meanwhile, Bubs Australia and The a2 Milk Company said they hope their “unique offerings”, and being a foreign brand, will set them apart in a competitive market where domestic brands are on the rise.

“Its absolutely critical that the Chinese government continues to produce domestic security and quality, it is very important for consumers to have that trust,” said Dennis Lin, chairman of Bubs Australia, which focuses on goat milk.

“At the same time the government cannot tell consumers what to buy, and consumers will always want to have that level of choice. And one of the key decisions is do I buy a foreign brand or domestic brand?” he said. “All we want is to have a seat at that table.”

The a2 Milk Company uses cows in New Zealand that produce milk containing A2 protein, thought to be healthier and easier to digest.

“There is no question there has been growth in the [market share]of domestic players, and there is increased confidence in products developed in China,” said chief executive officer Geoff Babidge. “It is a very large market, it is continuing to grow. Our view is there is space for a range of players, both domestic and international, that provide a solution to what the mothers are seeking.

“It’s the companies that can continue to deliver high quality products and unique attributes that engage with consumers [that will succeed].”

Purchase the China AI Report 2020 brought to you by SCMP Research and enjoy a 20% discount (original price US$400). This 60-page all new intelligence report gives you first-hand insights and analysis into the latest industry developments and intelligence about China AI. Get exclusive access to our webinars for continuous learning, and interact with China AI executives in live Q&A. Offer valid until 31 March 2020.